API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.globenewswire.com/news-release/2024/07/03/2908117/0/en/IntelGenx-Obtains-Preliminary-Efficacy-Results-for-the-BUENA-Montelukast-VersaFilm-Phase-2a-Clinical-Trial-in-Patients-with-Mild-to-Moderate-Alzheimer-s-Disease.html
https://www.reuters.com/business/healthcare-pharmaceuticals/new-york-attorney-general-urges-stronger-safety-warning-asthma-drug-singulair-2024-02-23/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-accused-downplaying-early-evidence-drugs-brain-impact-2023-06-26/
https://recalls-rappels.canada.ca/en/alert-recall/montelukast-chewable-tablet-out-specification
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-10-2023-12326.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-5-2023-55870.pdf
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-impurity-pro-doc-montelukast-sodium-5mg-1654327163.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205107
https://www.raps.org/news-and-articles/news-articles/2020/3/fda-requires-boxed-warning-for-singulair-generics
https://endpts.com/fda-requires-boxed-warning-for-singulair-and-its-generics/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213471
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-5-2020-1580878802.pdf
https://seekingalpha.com/news/3504689-intelgenx-mid-stage-study-montelukast-alzheimers-continue-planned
https://www.indiainfoline.com/article/news-top-story/glenmark-pharma-receives-approval-from-russian-ministry-of-healthcare-to-market-montlezir-119093000069_1.html
https://endpts.com/merck-touts-phase-iii-data-for-antibacterial-recarbrio-sanofi-to-ax-200-jobs-in-japan-report/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207464
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-3-2018-1538550050.pdf
https://www.biopharmadive.com/news/merck-ceo-to-stay-on-through-2019/533275/
https://www.turnto23.com/news/local-news/fda-announces-voluntary-recall-of-montelukast-sodium-tablets-used-to-treat-asthma
https://www.in-pharmatechnologist.com/Article/2018/09/03/Mix-up-leads-to-wrong-medicine-being-dispensed-to-patients
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210431
https://health.economictimes.indiatimes.com/news/pharma/twin-usfda-approvals-for-morepen-labs-bulk-drugs-api-facilities/65198515
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208621
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unichem-labs-gets-usfda-nod-for-asthma-drug/articleshow/64854672.cms
http://www.business-standard.com/article/markets/morepen-surges-18-on-usfda-clearance-for-anti-asthmatic-drug-montelukast-117122000225_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-21-2017-1498020666.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206112
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209011
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-5-2017-1491371454.pdf
http://www.fiercepharma.com/pharma/merck-falls-short-q4-sales-but-sees-eps-growth-ahead
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/morepen-to-sell-anti-asthmatic-drug-montelukast-in-europe-north-america/articleshow/50918672.cms
http://www.financialexpress.com/article/industry/companies/unimark-in-talks-to-sell-carbapenen-unit/183288/
http://www.prnewswire.com/news-releases/ajanta-pharma-announces-the-launch-of-montelukast-ir-tablets-and-montelukast-chewable-tablets-300188087.html
http://www.fiercepharma.com/story/advera-health-novartis-gsk-asthma-meds-linked-more-side-effects-merck-drugs/2015-11-18
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ajanta-pharma-launches-generic-asthma-drug-in-us-market/articleshow/49804882.cms
https://www.pharmacompass.com/pdf/news/anbisons-generic-montelukast-sodium-approved-in-us-for-bronchospasm-1447226884.pdf
https://www.pharmacompass.com/pdf/news/unichems-generic-montelukast-sodium-approved-in-us-for-asthma-1444910796.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unichem-gets-usfda-nod-for-generic-asthma-treatment-tablets/articleshow/49289839.cms
http://www.fiercepharma.com/story/merck-job-cutting-tensions-displayed-public-emails-frazier-union-rep/2015-08-19
https://www.pharmacompass.com/pdf/news/anbison-labs-generic-montelukast-sodium-approved-in-us-for-1452929272.pdf